ABVC BioPharma Inc

NAS:ABVCHealthcarenasdaq_composite

$0.9100−0.86%At closeAt close · Tue 20 Oct · ≈ AED 3.34 · Market cap $24.26M · Next earnings Mon 16 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	96.1%	98.6%	70.5%	−98.1%	99.9%	—	—	—
Operating margin	−1,760.9%	−3,290.1%	−1,558.5%	−4,439.2%	−923.3%	—	—	—
Net margin	−2,027.0%	−3,608.5%	−1,693.5%	−5,109.3%	−962.1%	—	—	—
EBITDA margin	−2,147.2%	−3,083.7%	−1,567.0%	−4,153.2%	−852.2%	—	—	—
Return on equity	−148.4%	−145.2%	−368.8%	−501.1%	−399.9%	−71.2%	−59.5%	+11.7 pts
Return on assets	−66.3%	−93.7%	−150.2%	−100.0%	−65.0%	−37.5%	−37.5%	+0.0 pts
Return on capital employed	−85.7%	−117.0%	−280.4%	−402.2%	−478.9%	−48.0%	—	—
Debt / equity	1.0×	0.4×	0.8×	1.8×	2.6×	0.3×	0.3×	−16.4%
Debt / assets	45.9%	24.4%	31.2%	35.6%	42.5%	16.5%	—	—
Interest coverage	−21.0×	−51.5×	−51.4×	−5.2×	−5.7×	−17.2×	—	—
Current ratio	1.3×	2.1×	0.5×	0.3×	0.3×	0.4×	0.4×	+0.0%
Quick ratio	1.3×	2.1×	0.5×	0.3×	0.3×	0.4×	—	—
Cash ratio	1.0×	1.6×	0.3×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.0×	0.1×	0.0×	—	—
Inventory turnover	—	0.2×	—	—	—	—	—	—
Receivables turnover	0.5×	0.8×	0.7×	0.2×	0.4×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.